BOGOTA, Colombia – A Brazilian pharma company based in Itapira, Sao Paulo, has obtained the very first biodiversity-based registration from Anvisa of a biological active pharmaceutical ingredient (API). Cristália's API is an enzyme called collagenase Cristalia, used in ointments to treat wounds, burns and necrotic tissue. To date, Brazil has had to rely on imports of collagenase.